Shattuck Labs Inc STTK

$6.73 -0.11 (-1.61%)

Valuation

Market cap
675,443,000
Revenue TTM
$1,000,000
Net income TTM
$-48,810,000
PE ratio
0.00
Forward PE
—
Profit margin
-4,881.00%
Debt to equity
0.00

Trading

Volume
1,843,700
Avg volume
1,126,348
Day's range
$6.54 – $7.09
Shares out
100,363,000
Stochastic %K
56%
Beta
1.09
Analysts
Strong Sell
Price target
$15.22

Price

Company profile

Shattuck Labs, Inc., a clinical-stage biotechnology company, engages in the development of antibodies for the treatment of inflammatory and immune-mediated diseases in the United States. The company develops SL-325, a death receptor 3 blocking monoclonal antibody, which is in Phase I clinical trial for the treatment of tumor necrosis factor like ligand 1A; and SL-425, a half-life extended version of SL-325, which is...

Show more

Shattuck Labs, Inc., a clinical-stage biotechnology company, engages in the development of antibodies for the treatment of inflammatory and immune-mediated diseases in the United States. The company develops SL-325, a death receptor 3 blocking monoclonal antibody, which is in Phase I clinical trial for the treatment of tumor necrosis factor like ligand 1A; and SL-425, a half-life extended version of SL-325, which is under IND-enabling chronic good laboratory practices toxicity study. It is also involved in the development of various preclinical DR3-based bispecific antibodies for the treatment of patients with inflammatory bowel disease or other immune-mediated indications; and TRIM7, an oncology-focused program. The company was incorporated in 2016 and is headquartered in Austin, Texas.

Industry
Biotechnology
Sector
Healthcare
Phone
512 900 4690
Website
https://www.shattucklabs.com
Address
500 West 5th Street, Suite 1200, Austin, United States

Latest news

Stocktwits

anachartanalyst Oct 2, 5:02 PM
$STTK https://anachart.com/wp-content/uploads/2026/10/1790960519_soc-img.jpg
0 replies
notreload_ai Sep 30, 5:03 PM
$MRK tulisokibart met its Phase 2b HS goal and will move to Phase 3. H.C. Wainwright sees first anti-TL1A skin data as a class plus for $STTK. https://notreload.xyz/xy/merck-hs-data-validates-tl1a-path-for-sttk/
0 replies
Zwisch Sep 30, 2:40 PM
$STTK Anybody for dinner tonight? Steak and eggs on me!
0 replies
kp8claw Sep 30, 2:20 PM
$STTK | $7.32 | Vol: 677K | RE·RVOL=0.40·F=68M | MUP_1 | Long
0 replies
Zwisch Sep 18, 7:52 PM
$STTK All in short squeeze next week oversold mean reversion back to the money supply and share demand before the Fed shat on the markets.
0 replies
DonDeutsch Sep 11, 12:12 AM
$STTK I bought the dip...
0 replies
YouVSYou Sep 9, 7:36 PM
$STTK Looks like free $$ down here
0 replies
NyseDayTrader Aug 24, 7:05 PM
$STTK
1 replies